FDA Approves New Trulicity Dosages

The FDA has approved 2 additional doses of Eli Lilly’s Trulicity (dulaglutide) for treating type 2 diabetes. The approval of the new 3.0 mg and 4.5 mg doses of dulaglutide was based on clinical trial results showing benefits for A1C levels and weight loss. Read more

Posted in Type II Drugs